The editorial board of The Wall Street Journal is coming out in opposition to Robert F. Kennedy Jr., President Trump’s pick to lead the Department of Health and Human Services (HHS).<\/p>\n
“Senate Republicans have an obligation to scrutinize his giant closet of business conflicts and dubious ideas,” the Journal wrote in an editorial<\/a> published Sunday ahead of Kennedy’s hearings<\/a> with the Senate Finance Committee on Wednesday and the Senate Committee on Health, Education, Labor and Pensions on Thursday.<\/p>\n The newspaper’s op-ed board said it expects Kennedy to “obfuscate about his ties to trial lawyers, anti-vaccine views, and support for sundry progressive causes,” while also “presenting himself as a truth-teller and slayer of government corruption, [even though] he\u2019s as slippery as\u00a0Anthony Fauci.”<\/p>\n “Most troubling is his long record of anti-vaccine advocacy,” the Journal wrote, noting the former presidential candidate has “tried to soften his vaccine skepticism since being nominated, and he now says he won\u2019t take away anyone\u2019s vaccines.”<\/p>\n The Rupert Murdoch-owned outlet mentioned that Kennedy’s financial disclosures show he has “received millions of dollars from referring clients to Wisner Baum and Morgan & Morgan, law firms that have sued vaccine and drug makers.”<\/p>\n “The risk is high that Mr. Kennedy will use his power and pulpit at HHS to enrich his trial-lawyer friends at the expense of public health and medical innovation,” the editorial board wrote. “Senators would be wise to believe RFK Jr.\u2019s career of spreading falsehoods rather than his confirmation conversions.” <\/p>\n